U.S. Food and Drug Administration FDA

4 Results / Page 1 of 1

Background

Health & Wellness

More than 2 Million COVID Home Tests Recalled Due to False Positive Results

HealthDay reports that an October recall of Ellume at-home COVID-19 test kits has now been expanded to include roughly 2 million of the 3.5 million tests that had been shipped to the United States by last month, the U.S. Food and Drug Administration said Tuesday. The original recall, involving 427,000 kits, was first announced in early October due to a "higher than acceptable" rate of false positives. It's a Class […]

todayNovember 15, 2021

Health & Wellness

FDA unanimously votes to approve Covid Vaccine Boosters – but ONLY for High-Risk Populations – for now

A U.S. Food and Drug Administration (FDA) committee voted unanimously Friday to recommend booster doses of Pfizer-BioNTech’s COVID-19 vaccine for those over age 65 and those at higher risk of exposure to the virus, including healthcare, frontline and essential workers, under emergency use authorization, but stopped short of recommending boosters for the general population. (Boosters have already been authorized for those with compromised immune systems.) Pfizer-BioNTech had originally requested that […]

todaySeptember 20, 2021

Health & Wellness

Pfizer seeks FDA approval for a Third “Booster” shot to specifically target the Delta Variant

Pfizer hopes to obtain U.S. approval for a third booster shot as the delta variant of the COVID-19 virus continues to spread worldwide, according to Reuters. Mikael Dolsten, the company’s Chief Scientific Officer, said the vaccine’s effectiveness tends to decline after six months as antibodies begin to wane. Hence, Pfizer suggests administering a third shot since a recent study showed promising signs against the virus with a five-to-ten-fold increase in […]

todayJuly 15, 2021

Health & Wellness

AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.

A large, Phase 3 study testing a Covid-19 vaccine being developed by AstraZeneca and the University of Oxford at dozens of sites across the U.S. has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom. A spokesperson for AstraZeneca, a frontrunner in the race for a Covid-19 vaccine, said in a statement that the company’s “standard review process triggered a pause […]

todaySeptember 14, 2020

Subscribe

LISTEN WITH YOUR APP

0%